Brokerages Set Intuitive Surgical, Inc. (NASDAQ:ISRG) PT at $554.17

Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) have been assigned a consensus rating of “Moderate Buy” from the nineteen brokerages that are presently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and fifteen have given a buy recommendation to the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $554.17.

A number of equities analysts have recently weighed in on the company. Evercore ISI reaffirmed a “cautious” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Piper Sandler reaffirmed an “overweight” rating and set a $538.00 price objective (up from $495.00) on shares of Intuitive Surgical in a report on Friday, October 18th. Royal Bank of Canada lifted their price objective on shares of Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research report on Friday, October 18th. Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and upped their target price for the stock from $522.00 to $650.00 in a research report on Monday, December 2nd. Finally, Leerink Partners lifted their price target on shares of Intuitive Surgical from $489.00 to $502.00 in a report on Thursday, October 17th.

Intuitive Surgical Trading Up 2.1 %

NASDAQ:ISRG opened at $535.29 on Thursday. The company has a 50 day simple moving average of $532.76 and a two-hundred day simple moving average of $490.65. The company has a market cap of $190.66 billion, a PE ratio of 86.06, a price-to-earnings-growth ratio of 5.31 and a beta of 1.38. Intuitive Surgical has a 12 month low of $320.26 and a 12 month high of $556.23.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The company had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. Research analysts forecast that Intuitive Surgical will post 5.45 earnings per share for the current year.

Insider Activity at Intuitive Surgical

In other news, CEO Gary S. Guthart sold 18,151 shares of the firm’s stock in a transaction dated Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the sale, the chief executive officer now directly owns 24,219 shares in the company, valued at approximately $12,391,166.97. This trade represents a 42.84 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Mark Brosius sold 2,128 shares of the business’s stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,095,920.00. Following the transaction, the senior vice president now owns 273 shares of the company’s stock, valued at approximately $140,595. This trade represents a 88.63 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 48,190 shares of company stock valued at $25,012,927 over the last ninety days. 0.90% of the stock is owned by company insiders.

Hedge Funds Weigh In On Intuitive Surgical

Institutional investors have recently bought and sold shares of the business. Convergence Investment Partners LLC purchased a new position in Intuitive Surgical during the second quarter valued at approximately $200,000. Legacy Capital Wealth Partners LLC acquired a new position in shares of Intuitive Surgical in the 2nd quarter valued at $411,000. Midland Wealth Advisors LLC purchased a new stake in Intuitive Surgical during the second quarter worth $246,000. Novare Capital Management LLC acquired a new stake in Intuitive Surgical during the second quarter valued at $219,000. Finally, Oregon Public Employees Retirement Fund increased its holdings in Intuitive Surgical by 1.2% in the second quarter. Oregon Public Employees Retirement Fund now owns 30,495 shares of the medical equipment provider’s stock valued at $13,566,000 after buying an additional 362 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.